Floatz logo

465 assets in Obesity Disorder

Therapeutic assets addressing Obesity Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Bmf-650
Obesity Disorder
Biomea Fusion Inc.P1C (36)
Brenipatide
Obesity Disorder
Eli Lilly and CompanyP1C (36)
Carbon Dioxide
Obesity Disorder
University of Missouri-ColumbiaEarly P1C (36)
da-1726
Obesity Disorder
NeuroBo Pharmaceuticals Inc.P1C (36)
Dextrose Solution
Obesity Disorder
Columbia UniversityP1C (36)
Follicle Stimulating Hormone
Obesity Disorder
University of Colorado, DenverP1C (36)
Gerpevir
Obesity Disorder
University Hospital, ToulouseP1C (36)
hm17321
Obesity Disorder
Hanmi Pharmaceutical Company LimitedP1C (36)
Inv-347
Obesity Disorder
Novo Nordisk A/SP1C (36)
ly3971297
Obesity Disorder
Eli Lilly and CompanyP1C (36)
ly41747794
Obesity Disorder
Eli Lilly and CompanyP1C (36)
Mbx 4291
Obesity Disorder
MBX BiosciencesP1C (36)
Neomycin
Obesity Disorder
Assaf Harofeh MCEarly P1C (36)
nnc0113-5840
Obesity Disorder
Novo Nordisk A/SP1C (36)
nnc0174-1213 a
Obesity Disorder
Novo Nordisk A/SP1C (36)
nnc0638-0355
Obesity Disorder
Novo Nordisk A/SP1C (36)
pg-102
Obesity Disorder
RANI TherapeuticsP1C (36)
RT-114
Obesity Disorder
RANI TherapeuticsP1C (36)
Shr-2906
Obesity Disorder
Beijing Suncadia Pharmaceuticals Co., LtdP1C (36)
Tlc-6740
Obesity Disorder
OrsoBio, IncP1C (36)
Vrb-103
Obesity Disorder
Verdiva Bio Dev LimitedP1C (36)
Xen-101
Obesity Disorder
Xeno BiosciencesP1C (36)
Acetazolamide
Obesity Disorder
University of ArizonaEarly P1C (33)
Apple Cider Vinegar
Obesity Disorder
Western UniversityEarly P1C (33)
Gip[3-30]Nh2
Obesity Disorder
Frederikke Koefoed-HansenEarly P1C (33)
Isoproterenol
Obesity Disorder
University of Missouri-ColumbiaEarly P1C (33)
Milk Polar Lipid-Rich Dairy Powder
Obesity Disorder
University of ConnecticutEarly P1C (33)
M-Sympathol
Obesity Disorder
University of Missouri-ColumbiaEarly P1C (33)
Neuropeptide Y Human
Obesity Disorder
University of Texas Southwestern Medical CenterEarly P1C (33)
Noradrenaline
Obesity Disorder
University of Missouri-ColumbiaEarly P1C (33)
Somatostatin
Obesity Disorder
University of CopenhagenEarly P1C (33)
13C labeled fructose
Obesity Disorder
Touro University, CaliforniaN/AD (30)
(2.ALPHA.,3.BETA.,4.ALPHA.)-2,3,23-TRIHYDROXYURS-12-EN-28-OIC ACID O-6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL-(1->4)-O-.BETA.-D-GLUCOPYRANOSYL-(1->6)-O-.BETA.-D-GLUCOPYRANOSYL ESTER
Obesity Disorder
Shanghai Zhongshan HospitalN/AD (30)
Akm Lab-01
Obesity Disorder
Moon (Guangzhou) Biotechnology Co., Ltd.N/AD (30)
Human Chorionic Gonadotropin
Obesity Disorder
The Second Hospital of Shandong UniversityN/AD (30)
Ketone Monoester
Obesity Disorder
University of MacauN/AD (30)
Lactulose
Obesity Disorder
Yale UniversityN/AD (30)
L-Bupivacaine
Obesity Disorder
IVO JURISICN/AD (30)
Modafinil
Obesity Disorder
Ain Shams UniversityN/AD (30)
N-Lactoyl-Phenylalanine
Obesity Disorder
University of AarhusN/AD (30)
Olea Europaea Oil
Obesity Disorder
Mucosa Innovations, S.L.N/AD (30)
Pancreatic Polypeptide
Obesity Disorder
University Hospital, Gentofte, CopenhagenN/AD (30)
PECANS
Obesity Disorder
University of GeorgiaN/AD (30)
Plants And Plant Parts, Hemp
Obesity Disorder
USDA Beltsville Human Nutrition Research CenterN/AD (30)
Rebaudioside A
Obesity Disorder
Midwest Center for Metabolic and Cardiovascular ResearchN/AD (30)
Remimazolam
Obesity Disorder
RenJi HospitalN/AD (30)
Sodium Chloride
Obesity Disorder
University of AarhusN/AD (30)
Sodium Phenylbutyrate
Obesity Disorder
University of NottinghamN/AD (30)
Soybean Oil
Obesity Disorder
Ohio State UniversityN/AD (30)
Showing 351 to 400 of 465 assets
PreviousPage 8 of 10Next